Roche €1.5bn deal keeps primary firing into month end

© 2025 GlobalCapital, Derivia Intelligence Limited, company number 15235970, 4 Bouverie Street, London, EC4Y 8AX. Part of the Delinian group. All rights reserved.

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement | Event Participant Terms & Conditions

Cookies Settings
Corporate Bonds

Roche €1.5bn deal keeps primary firing into month end

Mike Turner
November 27, 2023 03:23 pm
Roche Madopar capsules for treatment of parkinsons disease. Image shot 2008. Exact date unknown.

Euro primary continues pumping out trades with JDE Peet's and Covivio lining up

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Request a Free Trial or Login

Topics

Corporate BondsHigh grade and crossover bondsEuroEuropeSwitzerlandHealth and Biotech
MT
Mike Turner
Corporate Debt Editor
Contact
Gift this article